Literature DB >> 30602605

Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.

GuanQun Liu1,2, Yao Lu1,3, Qiang Liu1,2,3, Yan Zhou4,2,3.   

Abstract

Pattern recognition receptors provide essential nonself immune surveillance within distinct cellular compartments. Retinoic acid-inducible gene I (RIG-I) is one of the primary cytosolic RNA sensors, with an emerging role in the nucleus. It is involved in the spatiotemporal sensing of influenza A virus (IAV) replication, leading to the induction of type I interferons (IFNs). Nonetheless, the physiological viral ligands activating RIG-I during IAV infection remain underexplored. Other than full-length viral genomes, cellular constraints that impede ongoing viral replication likely potentiate an erroneous viral polymerase generating aberrant viral RNA species with RIG-I-activating potential. Here, we investigate the origins of RIG-I-activating viral RNA under two such constraints. Using chemical inhibitors that inhibit continuous viral protein synthesis, we identify the incoming, but not de novo-synthesized, viral defective interfering (DI) genomes contributing to RIG-I activation. In comparison, deprivation of viral nucleoprotein (NP), the key RNA chain elongation factor for the viral polymerase, leads to the production of aberrant viral RNA species activating RIG-I; however, their nature is likely to be distinct from that of DI RNA. Moreover, RIG-I activation in response to NP deprivation is not adversely affected by expression of the nuclear export protein (NEP), which diminishes the generation of a major subset of aberrant viral RNA but facilitates the accumulation of small viral RNA (svRNA). Overall, our results indicate the existence of fundamentally different mechanisms of RIG-I activation under cellular constraints that impede ongoing IAV replication.IMPORTANCE The induction of an IFN response by IAV is mainly mediated by the RNA sensor RIG-I. The physiological RIG-I ligands produced during IAV infection are not fully elucidated. Cellular constraints leading to the inhibition of ongoing viral replication likely potentiate an erroneous viral polymerase producing aberrant viral RNA species activating RIG-I. Here, we demonstrate that RIG-I activation during chemical inhibition of continuous viral protein synthesis is attributable to the incoming DI genomes. Erroneous viral replication driven by NP deprivation promotes the generation of RIG-I-activating aberrant viral RNA, but their nature is likely to be distinct from that of DI RNA. Our results thus reveal distinct mechanisms of RIG-I activation by IAV under cellular constraints impeding ongoing viral replication. A better understanding of RIG-I sensing of IAV infection provides insight into the development of novel interventions to combat influenza virus infection.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Influenza A virus; RIG-I; aberrant RNA; defective interfering RNA; innate immunity; interferon

Mesh:

Substances:

Year:  2019        PMID: 30602605      PMCID: PMC6401434          DOI: 10.1128/JVI.02066-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication.

Authors:  Agustín Portela; Paul Digard
Journal:  J Gen Virol       Date:  2002-04       Impact factor: 3.891

2.  Influenza A virus-generated small RNAs regulate the switch from transcription to replication.

Authors:  Jasmine T Perez; Andrew Varble; Ravi Sachidanandam; Ivan Zlatev; Muthiah Manoharan; Adolfo García-Sastre; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 3.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

4.  RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

Authors:  Jan Rehwinkel; Choon Ping Tan; Delphine Goubau; Oliver Schulz; Andreas Pichlmair; Katja Bier; Nicole Robb; Frank Vreede; Wendy Barclay; Ervin Fodor; Caetano Reis e Sousa
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

5.  RNA interference of influenza A virus replication by microRNA-adapted lentiviral loop short hairpin RNA.

Authors:  Fang Xu; Guanqun Liu; Qiang Liu; Yan Zhou
Journal:  J Gen Virol       Date:  2015-07-17       Impact factor: 3.891

6.  RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.

Authors:  Andreas Pichlmair; Oliver Schulz; Choon Ping Tan; Tanja I Näslund; Peter Liljeström; Friedemann Weber; Caetano Reis e Sousa
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

7.  Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1.

Authors:  S K Biswas; D P Nayak
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 8.  Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier.

Authors:  Benjamin Mänz; Martin Schwemmle; Linda Brunotte
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus.

Authors:  Kazima Saira; Xudong Lin; Jay V DePasse; Rebecca Halpin; Alan Twaddle; Timothy Stockwell; Brian Angus; Alessandro Cozzi-Lepri; Marina Delfino; Vivien Dugan; Dominic E Dwyer; Matthew Freiberg; Andrzej Horban; Marcelo Losso; Ruth Lynfield; Deborah N Wentworth; Edward C Holmes; Richard Davey; David E Wentworth; Elodie Ghedin
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

10.  Influenza A virus preferentially snatches noncoding RNA caps.

Authors:  Weifeng Gu; Glen R Gallagher; Weiwei Dai; Ping Liu; Ruidong Li; Melanie I Trombly; Don B Gammon; Craig C Mello; Jennifer P Wang; Robert W Finberg
Journal:  RNA       Date:  2015-10-01       Impact factor: 4.942

View more
  13 in total

Review 1.  Cytoplasm and Beyond: Dynamic Innate Immune Sensing of Influenza A Virus by RIG-I.

Authors:  GuanQun Liu; Yan Zhou
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 2.  Know Thyself: RIG-I-Like Receptor Sensing of DNA Virus Infection.

Authors:  Yang Zhao; John Karijolich
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

Review 3.  Structure and Function of the Influenza Virus Transcription and Replication Machinery.

Authors:  Ervin Fodor; Aartjan J W Te Velthuis
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 6.915

Review 4.  Interplay between host non-coding RNAs and influenza viruses.

Authors:  Gayan Bamunuarachchi; Samuel Pushparaj; Lin Liu
Journal:  RNA Biol       Date:  2021-01-18       Impact factor: 4.652

Review 5.  Influenza Virus RNA Synthesis and the Innate Immune Response.

Authors:  Sabrina Weis; Aartjan J W Te Velthuis
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

6.  Single-Cell Virus Sequencing of Influenza Infections That Trigger Innate Immunity.

Authors:  Alistair B Russell; Elizaveta Elshina; Jacob R Kowalsky; Aartjan J W Te Velthuis; Jesse D Bloom
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

7.  Ganghuo Kanggan Decoction in Influenza: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation.

Authors:  Yanni Lai; Qiong Zhang; Haishan Long; Tiantian Han; Geng Li; Shaofeng Zhan; Yiwei Li; Zonghui Li; Yong Jiang; Xiaohong Liu
Journal:  Front Pharmacol       Date:  2020-12-10       Impact factor: 5.810

Review 8.  Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5.

Authors:  Morgan Brisse; Hinh Ly
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

Review 9.  Innate Immune Sensing of Influenza A Virus.

Authors:  Gaurav Malik; Yan Zhou
Journal:  Viruses       Date:  2020-07-14       Impact factor: 5.048

10.  Cell type- and replication stage-specific influenza virus responses in vivo.

Authors:  Elizabeth J Fay; Stephanie L Aron; Marissa G Macchietto; Matthew W Markman; Katharina Esser-Nobis; Michael Gale; Steven Shen; Ryan A Langlois
Journal:  PLoS Pathog       Date:  2020-08-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.